Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL19,C-C motif chemokine 19,Inverse variance weighted,16,1.3 [1.14-1.49],0.000130541541006383,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,16,1.19 [1.08-1.31],0.000403669565331363,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TYMP,Thymidine phosphorylase,Inverse variance weighted,16,1.18 [1.07-1.3],0.000625445830286364,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POF1B,Protein POF1B,Inverse variance weighted,16,1.17 [1.07-1.27],0.000728133354685898,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,16,1.41 [1.15-1.72],0.000767205945954625,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,Inverse variance weighted,16,1.15 [1.06-1.25],0.00103264256478161,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL17,C-C motif chemokine 17,Inverse variance weighted,16,1.17 [1.07-1.29],0.00110655608134559,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,16,1.41 [1.15-1.73],0.00111695949541429,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA6,Carbonic anhydrase 6,Inverse variance weighted,16,0.9 [0.85-0.96],0.00115191414710686,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,16,1.29 [1.1-1.51],0.00174569276297414,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",Inverse variance weighted,16,1.15 [1.05-1.25],0.00183983976847922,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JAM3,Junctional adhesion molecule C,Inverse variance weighted,16,1.13 [1.05-1.22],0.00198370107716136,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL5,C-C motif chemokine 5,Inverse variance weighted,16,1.18 [1.06-1.32],0.00254611174198599,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,16,1.12 [1.04-1.22],0.00309229273413976,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTGES2,Prostaglandin E synthase 2,Inverse variance weighted,16,1.11 [1.04-1.19],0.00328813824277627,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS4,Galectin-4,Inverse variance weighted,16,1.14 [1.04-1.24],0.00335552547759237,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAP2,Microtubule-associated protein 2,Inverse variance weighted,16,1.16 [1.05-1.29],0.00417458162432809,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GSR,"Glutathione reductase, mitochondrial",Inverse variance weighted,16,1.12 [1.04-1.2],0.00418649299427565,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,16,1.12 [1.04-1.21],0.00432786060918887,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,16,1.14 [1.04-1.25],0.00478955352124775,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPL,N-acetylneuraminate lyase,Inverse variance weighted,16,1.32 [1.09-1.6],0.00482336722038697,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,16,1.11 [1.03-1.2],0.00494545861891569,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,16,1.11 [1.03-1.2],0.00499654003573235,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HHEX,Hematopoietically-expressed homeobox protein HHEX,Inverse variance weighted,16,1.19 [1.05-1.34],0.0055868398839546,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Inverse variance weighted,16,1.14 [1.04-1.26],0.00569185089575377,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,16,1.16 [1.04-1.29],0.00582825435480758,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PAXX,Protein PAXX,Inverse variance weighted,16,1.16 [1.04-1.29],0.00658807281935522,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,16,1.12 [1.03-1.21],0.00666924995168874,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FUOM,Fucose mutarotase,Inverse variance weighted,16,1.13 [1.03-1.24],0.00671401373922557,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,16,1.13 [1.03-1.24],0.00703774034855827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3D,Protein FAM3D,Inverse variance weighted,16,1.09 [1.02-1.15],0.0070935749856096,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,16,1.13 [1.03-1.24],0.00723352124109682,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OCLN,Occludin,Inverse variance weighted,16,1.13 [1.03-1.25],0.0078751617884294,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,Inverse variance weighted,16,1.15 [1.04-1.28],0.00808786561259655,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,16,1.14 [1.03-1.25],0.0085398743021635,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,16,1.1 [1.02-1.17],0.00854905512822452,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG1A,Lithostathine-1-alpha,Inverse variance weighted,16,1.09 [1.02-1.16],0.00871906791593913,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,16,1.21 [1.05-1.39],0.0093939814169817,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,16,1.17 [1.04-1.31],0.0102193390827462,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,16,1.1 [1.02-1.18],0.0103190118813889,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL7,C-C motif chemokine 7,Inverse variance weighted,16,1.12 [1.03-1.23],0.0105080279738558,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,16,1.1 [1.02-1.18],0.010765631169807,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLF4,Krueppel-like factor 4,Inverse variance weighted,16,1.09 [1.02-1.17],0.011131568276654,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL3,C-C motif chemokine 3,Inverse variance weighted,16,1.19 [1.04-1.37],0.0112618916602074,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPY30,Protein dpy-30 homolog,Inverse variance weighted,16,1.15 [1.03-1.27],0.0112824464615653,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GRN,Progranulin,Inverse variance weighted,16,1.13 [1.03-1.24],0.0119872611234831,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,16,1.34 [1.07-1.68],0.0120782598693787,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.29 [1.06-1.57],0.01229523118083,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,16,1.11 [1.02-1.21],0.0126618468654776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLIN3,Perilipin-3,Inverse variance weighted,16,1.09 [1.02-1.16],0.015216657543066,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,P4HB,Protein disulfide-isomerase,Inverse variance weighted,16,1.14 [1.03-1.28],0.0163253802206207,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,16,1.12 [1.02-1.22],0.0165303063078079,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMNB1,Lamin-B1,Inverse variance weighted,16,1.09 [1.02-1.16],0.0166624856896327,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,16,1.12 [1.02-1.24],0.0171881452169181,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP2,Retinol-binding protein 2,Inverse variance weighted,16,1.09 [1.01-1.16],0.0174583498963686,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,16,1.1 [1.02-1.2],0.0180693023042785,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIAE,Sialate O-acetylesterase,Inverse variance weighted,16,1.16 [1.02-1.3],0.018358849808734,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HMOX2,Heme oxygenase 2,Inverse variance weighted,16,1.11 [1.02-1.22],0.0186564683980366,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,16,1.14 [1.02-1.27],0.0187850160971124,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINH1,Serpin H1,Inverse variance weighted,16,1.13 [1.02-1.26],0.0192003859267178,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,16,1.21 [1.03-1.41],0.0192444586620524,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP12,Macrophage metalloelastase,Inverse variance weighted,16,1.1 [1.02-1.19],0.0193736597960998,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,16,1.17 [1.03-1.34],0.0194923236745138,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL4,C-C motif chemokine 4,Inverse variance weighted,16,1.17 [1.02-1.33],0.0199749949802571,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL20,C-C motif chemokine 20,Inverse variance weighted,16,1.11 [1.02-1.2],0.0203055139680589,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,16,1.12 [1.02-1.23],0.0213310802527269,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BPIFA2,BPI fold-containing family A member 2,Inverse variance weighted,16,0.93 [0.87-0.99],0.0215112014846643,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,16,1.09 [1.01-1.17],0.0224035105763827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,16,1.1 [1.01-1.2],0.0238727020455722,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGR3,Anterior gradient protein 3,Inverse variance weighted,16,1.08 [1.01-1.16],0.0244934845480153,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,16,1.12 [1.02-1.25],0.0247649257484917,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,16,1.32 [1.04-1.67],0.0249384339655075,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,16,1.09 [1.01-1.17],0.026048643301827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,16,1.25 [1.03-1.52],0.0261837440664327,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,16,1.12 [1.01-1.23],0.0261906758349997,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TMSB10,Thymosin beta-10,Inverse variance weighted,16,1.15 [1.02-1.29],0.0264821060421285,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPPC,C-type natriuretic peptide,Inverse variance weighted,16,1.09 [1.01-1.18],0.0267445841777913,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,16,0.92 [0.85-0.99],0.0268237863547265,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,16,1.18 [1.02-1.37],0.0270423515237049,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,16,1.1 [1.01-1.2],0.0275345357090547,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CALCA,Calcitonin,Inverse variance weighted,16,1.1 [1.01-1.2],0.0275366079920846,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,16,1.09 [1.01-1.17],0.027674407189019,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Inverse variance weighted,16,1.12 [1.01-1.25],0.0283028802884645,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,F11R,Junctional adhesion molecule A,Inverse variance weighted,16,1.16 [1.02-1.33],0.0285660846902533,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF6,SLAM family member 6,Inverse variance weighted,16,1.14 [1.01-1.27],0.029565033881601,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GLA,Alpha-galactosidase A,Inverse variance weighted,16,1.17 [1.02-1.36],0.0301265627575985,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MDK,Midkine,Inverse variance weighted,16,1.18 [1.02-1.37],0.0302362625218737,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,16,1.1 [1.01-1.19],0.0310713475759356,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD46,Membrane cofactor protein,Inverse variance weighted,16,1.09 [1.01-1.18],0.0312052376022809,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,16,1.11 [1.01-1.22],0.0313564064851207,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,16,1.12 [1.01-1.24],0.0314181109783122,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,16,1.11 [1.01-1.21],0.0314344479565697,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,16,1.12 [1.01-1.24],0.0319280637578896,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,16,1.1 [1.01-1.2],0.0324484971930945,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,16,1.22 [1.02-1.46],0.0335519612090202,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,16,0.93 [0.86-0.99],0.033705348917647,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GIGYF2,GRB10-interacting GYF protein 2,Inverse variance weighted,16,1.09 [1-1.19],0.0384045500101645,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AGRN,Agrin,Inverse variance weighted,16,1.1 [1-1.2],0.0386466836315822,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,16,0.87 [0.77-0.99],0.0401523171688845,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PPP3R1,Calcineurin subunit B type 1,Inverse variance weighted,16,1.11 [1-1.24],0.0414195747338367,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP6,Gastrotropin,Inverse variance weighted,16,1.1 [1-1.22],0.041442524797317,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAPK9,Mitogen-activated protein kinase 9,Inverse variance weighted,16,1.1 [1-1.2],0.0420421600390983,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,16,1.21 [1.01-1.45],0.0420830895026825,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,16,1.21 [1.01-1.46],0.0424398268502628,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,16,1.08 [1-1.17],0.0428790900032011,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL18,C-C motif chemokine 18,Inverse variance weighted,16,1.11 [1-1.24],0.0429359593885517,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NECTIN2,Nectin-2,Inverse variance weighted,16,1.09 [1-1.19],0.0434476222879506,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,16,1.07 [1-1.14],0.0441132404208223,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,16,1.13 [1-1.27],0.045253212851245,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,16,1.2 [1-1.43],0.0454205463362756,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN5,Contactin-5,Inverse variance weighted,16,0.9 [0.81-1],0.0463470414688748,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG1B,Lithostathine-1-beta,Inverse variance weighted,16,1.08 [1-1.16],0.0464245177587893,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,16,1.09 [1-1.2],0.0464980133009912,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,16,1.26 [1-1.57],0.0469023596960229,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,16,1.15 [1-1.32],0.0470674717495444,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18,Interleukin-18,Inverse variance weighted,16,1.14 [1-1.29],0.0471825047143385,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GBP1,Guanylate-binding protein 1,Inverse variance weighted,16,1.23 [1-1.51],0.0472433516164181,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,16,1.13 [1-1.28],0.0476301148634922,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MUC13,Mucin-13,Inverse variance weighted,16,1.12 [1-1.26],0.0480820974816135,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MLN,Promotilin,Inverse variance weighted,16,1.08 [1-1.17],0.0494975770487801,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,B2M,Beta-2-microglobulin,Inverse variance weighted,16,1.21 [1-1.47],0.0520555085758146,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYL3,Myosin light chain 3,Inverse variance weighted,16,0.92 [0.84-1],0.0533321689910552,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA9,Carbonic anhydrase 9,Inverse variance weighted,16,0.92 [0.84-1],0.0547389442973903,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFC1,Cryptic protein,Inverse variance weighted,16,0.94 [0.87-1],0.0550511644548755,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MARCO,Macrophage receptor MARCO,Inverse variance weighted,16,1.11 [1-1.23],0.0551551016135119,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS1,Galectin-1,Inverse variance weighted,16,1.07 [1-1.14],0.055288745009115,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,16,1.1 [1-1.21],0.0554049211047152,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RSPO1,R-spondin-1,Inverse variance weighted,16,1.13 [1-1.29],0.0567315110534105,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDIA3,Protein disulfide-isomerase A3,Inverse variance weighted,16,1.07 [1-1.15],0.0571489156736082,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,16,1.11 [1-1.23],0.0585061166149443,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,16,0.92 [0.84-1],0.0590835340294994,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UBQLN3,Ubiquilin-3,Inverse variance weighted,16,1.09 [1-1.19],0.0591424058839313,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GUCA2A,Guanylin,Inverse variance weighted,16,1.11 [1-1.23],0.0599770505437443,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL25,C-C motif chemokine 25,Inverse variance weighted,16,1.09 [1-1.19],0.0618376654135424,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,16,1.14 [0.99-1.3],0.0620486122503884,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,16,1.11 [0.99-1.25],0.0638750198259931,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,16,0.91 [0.83-1.01],0.0640981715539662,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XCL1,Lymphotactin,Inverse variance weighted,16,1.18 [0.99-1.42],0.065659389643107,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL23,C-C motif chemokine 23,Inverse variance weighted,16,1.16 [0.99-1.35],0.0660799977960091,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,16,1.09 [0.99-1.19],0.0661313670456224,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FOLR1,Folate receptor alpha,Inverse variance weighted,16,0.93 [0.86-1.01],0.0688646241835784,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.13 [0.99-1.29],0.0706554453011082,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS9,Galectin-9,Inverse variance weighted,16,1.15 [0.99-1.33],0.0710504215922566,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,16,0.86 [0.74-1.01],0.0712909592207557,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GOLM2,Protein GOLM2,Inverse variance weighted,16,1.11 [0.99-1.24],0.0714114195061322,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DNM3,Dynamin-3,Inverse variance weighted,16,1.08 [0.99-1.17],0.0722997241942283,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Inverse variance weighted,16,1.07 [0.99-1.14],0.0725782328410405,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THOP1,Thimet oligopeptidase,Inverse variance weighted,16,1.08 [0.99-1.18],0.0728191994353471,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYOM3,Myomesin-3,Inverse variance weighted,16,0.9 [0.81-1.01],0.0732857590935097,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1.17 [0.98-1.4],0.0739713840083294,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,16,1.1 [0.99-1.23],0.0748978699439385,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NUCB2,Nucleobindin-2,Inverse variance weighted,16,1.12 [0.99-1.26],0.0751376170125631,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,16,1.06 [0.99-1.14],0.0761170751795829,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,16,1.14 [0.99-1.31],0.0764160470609642,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MVK,Mevalonate kinase,Inverse variance weighted,16,1.11 [0.99-1.24],0.0764520938437776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GFER,FAD-linked sulfhydryl oxidase ALR,Inverse variance weighted,16,1.08 [0.99-1.17],0.0781054562018726,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,16,1.11 [0.99-1.24],0.0784328498372346,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OGFR,Opioid growth factor receptor,Inverse variance weighted,16,1.11 [0.99-1.25],0.0786880129971629,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,16,1.09 [0.99-1.2],0.0805214084300788,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GAST,Gastrin,Inverse variance weighted,16,1.07 [0.99-1.16],0.0808000142028034,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KITLG,Kit ligand,Inverse variance weighted,16,0.93 [0.86-1.01],0.0809731467217513,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PSIP1,PC4 and SFRS1-interacting protein,Inverse variance weighted,16,1.11 [0.99-1.24],0.0812298739864851,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.06 [0.99-1.14],0.0812623294357989,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,16,1.07 [0.99-1.16],0.083031267816869,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL16,Pro-interleukin-16,Inverse variance weighted,16,1.08 [0.99-1.18],0.0833890569255509,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,16,1.06 [0.99-1.13],0.0863137101396549,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,16,1.11 [0.98-1.25],0.087902847020726,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Inverse variance weighted,16,1.12 [0.98-1.27],0.0881749482705779,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ELN,Elastin,Inverse variance weighted,16,0.94 [0.87-1.01],0.0897583066123918,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,16,0.94 [0.88-1.01],0.0901748307105829,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,16,0.91 [0.81-1.02],0.0907809853047245,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",Inverse variance weighted,16,1.1 [0.98-1.24],0.091667829422901,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,16,1.12 [0.98-1.28],0.0917915961347369,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DKK4,Dickkopf-related protein 4,Inverse variance weighted,16,1.08 [0.99-1.18],0.0921456788905543,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,16,1.2 [0.97-1.49],0.0926741130180943,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,16,1.09 [0.99-1.2],0.0931219126870406,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,16,1.09 [0.98-1.21],0.0937509606096939,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,16,1.09 [0.98-1.22],0.0952204374478876,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,16,1.12 [0.98-1.28],0.0958817777598736,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,16,0.94 [0.87-1.01],0.0970656681281723,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HYAL1,Hyaluronidase-1,Inverse variance weighted,16,1.07 [0.99-1.17],0.097086960024646,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL21,C-C motif chemokine 21,Inverse variance weighted,16,1.13 [0.98-1.31],0.0975332755800798,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCGN,Secretagogin,Inverse variance weighted,16,1.09 [0.98-1.2],0.0975676252656427,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,16,0.94 [0.88-1.01],0.0979274161970247,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.21 [0.97-1.5],0.0983363467396318,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PYY,Peptide YY,Inverse variance weighted,16,1.09 [0.98-1.22],0.0989929802297577,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEMA3F,Semaphorin-3F,Inverse variance weighted,16,1.11 [0.98-1.26],0.0996811580276321,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LMNB2,Lamin-B2,Inverse variance weighted,16,1.09 [0.98-1.21],0.100669546250181,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DCN,Decorin,Inverse variance weighted,16,0.89 [0.78-1.02],0.101320114726368,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,16,1.17 [0.97-1.43],0.104761872631039,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNC,Tenascin,Inverse variance weighted,16,1.07 [0.99-1.16],0.107232203262415,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KYNU,Kynureninase,Inverse variance weighted,16,1.11 [0.98-1.27],0.107534742181382,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,16,1.16 [0.97-1.39],0.108606750660666,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,16,1.15 [0.97-1.36],0.108672222372275,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,16,1.14 [0.97-1.33],0.109228430124625,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,16,0.92 [0.83-1.02],0.111925757659805,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,16,1.14 [0.97-1.33],0.111935814865178,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,16,1.06 [0.99-1.13],0.111970599147954,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,16,1.07 [0.98-1.17],0.112329286600007,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,16,1.08 [0.98-1.2],0.114086059800604,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGF,Placenta growth factor,Inverse variance weighted,16,1.08 [0.98-1.18],0.114194298769816,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,16,1.09 [0.98-1.2],0.115865069705922,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,16,1.12 [0.97-1.29],0.118637882263431,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PALM,Paralemmin-1,Inverse variance weighted,16,0.92 [0.82-1.02],0.120261809382624,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSTB,Cystatin-B,Inverse variance weighted,16,1.06 [0.98-1.15],0.120400238485793,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,16,1.21 [0.95-1.55],0.123784558836624,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE4,Ribonuclease 4,Inverse variance weighted,16,1.11 [0.97-1.28],0.124441322678195,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGA4,Pepsin A-4,Inverse variance weighted,16,0.94 [0.88-1.02],0.124588891425178,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSLN,Mesothelin,Inverse variance weighted,16,1.07 [0.98-1.17],0.124698337958663,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BRK1,Protein BRICK1,Inverse variance weighted,16,1.07 [0.98-1.16],0.128539318076951,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD83,CD83 antigen,Inverse variance weighted,16,1.18 [0.95-1.46],0.131950626007836,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,16,1.09 [0.97-1.22],0.132046610710556,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,16,1.06 [0.98-1.15],0.133585858357736,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,16,0.93 [0.84-1.02],0.134398896135815,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL14,C-C motif chemokine 14,Inverse variance weighted,16,1.07 [0.98-1.18],0.13660525590539,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,16,0.92 [0.83-1.03],0.138852955479844,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CST3,Cystatin-C,Inverse variance weighted,16,1.09 [0.97-1.23],0.139116685148592,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,16,1.13 [0.96-1.32],0.13946782697149,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,16,1.19 [0.95-1.49],0.14012607929502,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGA11,Integrin alpha-11,Inverse variance weighted,16,0.89 [0.76-1.04],0.140861612183956,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,16,1.08 [0.98-1.19],0.142698937621221,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSL,Cathepsin L1,Inverse variance weighted,16,1.05 [0.98-1.13],0.143114699445387,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,16,0.94 [0.87-1.02],0.14414014520446,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,16,0.93 [0.83-1.03],0.144402284364522,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,16,1.1 [0.97-1.24],0.144639620747923,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CBLN4,Cerebellin-4,Inverse variance weighted,16,0.92 [0.83-1.03],0.144664363934649,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SDC4,Syndecan-4,Inverse variance weighted,16,1.08 [0.98-1.19],0.14500417426931,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,16,0.94 [0.87-1.02],0.146125817373437,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL27,C-C motif chemokine 27,Inverse variance weighted,16,1.09 [0.97-1.22],0.146687799174453,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,16,1.06 [0.98-1.15],0.148879241714337,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PPL,Periplakin,Inverse variance weighted,16,1.05 [0.98-1.13],0.149510085627328,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HNMT,Histamine N-methyltransferase,Inverse variance weighted,16,1.05 [0.98-1.12],0.150402895438043,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,16,0.95 [0.89-1.02],0.151264582050382,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,16,1.14 [0.95-1.36],0.151705904177544,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCG2,Secretogranin-2,Inverse variance weighted,16,0.95 [0.89-1.02],0.154973549239157,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFA,Protransforming growth factor alpha,Inverse variance weighted,16,1.11 [0.96-1.28],0.155219429440598,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MSTN,Growth/differentiation factor 8,Inverse variance weighted,16,0.91 [0.81-1.04],0.155853341933197,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL15,C-C motif chemokine 15,Inverse variance weighted,16,1.07 [0.98-1.17],0.158022766034091,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSS,Cathepsin S,Inverse variance weighted,16,1.1 [0.96-1.26],0.158399923314989,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,16,1.06 [0.98-1.14],0.158547402056288,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MATN3,Matrilin-3,Inverse variance weighted,16,0.95 [0.88-1.02],0.158982054451457,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,16,1.09 [0.97-1.22],0.159202157884531,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,16,0.92 [0.82-1.03],0.159202993094746,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PSAP,Prosaposin,Inverse variance weighted,16,1.11 [0.96-1.28],0.160223462448193,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CA12,Carbonic anhydrase 12,Inverse variance weighted,16,0.89 [0.75-1.05],0.161753916411011,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN3,CCN family member 3,Inverse variance weighted,16,0.93 [0.84-1.03],0.162604557032745,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,16,1.09 [0.97-1.22],0.162917789432742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,16,1.1 [0.96-1.25],0.163771121422411,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FBLN2,Fibulin-2,Inverse variance weighted,16,0.91 [0.8-1.04],0.165508263888737,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSD,Cathepsin D,Inverse variance weighted,16,1.13 [0.95-1.34],0.16769245177144,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,16,0.89 [0.76-1.05],0.168536477572648,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,16,1.19 [0.93-1.51],0.171067841190667,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,16,1.07 [0.97-1.17],0.1718328880651,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLMP,CXADR-like membrane protein,Inverse variance weighted,16,0.92 [0.81-1.04],0.173640294495772,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP1,Interstitial collagenase,Inverse variance weighted,16,1.08 [0.97-1.21],0.176101824298285,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASET2,Ribonuclease T2,Inverse variance weighted,16,1.1 [0.96-1.26],0.178617140617772,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC3B,Tetranectin,Inverse variance weighted,16,0.92 [0.82-1.04],0.18000812820666,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,16,1.06 [0.98-1.14],0.180240712590909,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANG,Angiogenin,Inverse variance weighted,16,1.07 [0.97-1.19],0.183817428463145,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,16,1.07 [0.97-1.17],0.183869941728817,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADA2,Adenosine deaminase 2,Inverse variance weighted,16,1.19 [0.92-1.54],0.184410743622944,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,16,0.93 [0.83-1.04],0.185304238661092,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCLY,Selenocysteine lyase,Inverse variance weighted,16,1.1 [0.96-1.26],0.186790719148396,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,1.14 [0.94-1.39],0.187856405867198,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,16,1.08 [0.96-1.22],0.188198392409514,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,16,1.12 [0.95-1.32],0.188301401002001,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPR15L,Protein GPR15L,Inverse variance weighted,16,1.07 [0.97-1.18],0.190861450499547,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",Inverse variance weighted,16,1.09 [0.96-1.23],0.193526051987139,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGMN,Legumain,Inverse variance weighted,16,1.06 [0.97-1.15],0.193543721012712,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP7,Retinoid-binding protein 7,Inverse variance weighted,16,1.05 [0.97-1.13],0.200400403976257,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBP5,Retinol-binding protein 5,Inverse variance weighted,16,1.08 [0.96-1.22],0.201482994730265,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,16,1.15 [0.93-1.43],0.203285553339026,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,1.08 [0.96-1.21],0.205881549963255,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFNA1,Ephrin-A1,Inverse variance weighted,16,1.06 [0.97-1.15],0.207276167394209,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,16,1.07 [0.96-1.2],0.209226042313032,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF8,SLAM family member 8,Inverse variance weighted,16,1.12 [0.94-1.33],0.20942991520832,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JAM2,Junctional adhesion molecule B,Inverse variance weighted,16,0.91 [0.79-1.05],0.209778198528702,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LCP1,Plastin-2,Inverse variance weighted,16,1.04 [0.98-1.12],0.209838362788461,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,JUN,Transcription factor AP-1,Inverse variance weighted,16,0.96 [0.89-1.03],0.211131642214488,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,16,1.17 [0.91-1.51],0.211339393623249,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,16,0.93 [0.83-1.04],0.21221599780618,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PENK,Proenkephalin-A,Inverse variance weighted,16,1.04 [0.98-1.12],0.212603255700721,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,16,0.95 [0.88-1.03],0.21304527008955,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,16,1.06 [0.97-1.16],0.213538809533854,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,1.13 [0.93-1.37],0.214379676233266,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCL16,C-C motif chemokine 16,Inverse variance weighted,16,1.07 [0.96-1.18],0.214427671596143,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTN,Pleiotrophin,Inverse variance weighted,16,1.06 [0.97-1.15],0.215371599399031,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN2,Contactin-2,Inverse variance weighted,16,0.95 [0.88-1.03],0.215445037053531,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,16,1.25 [0.88-1.77],0.217323334920428,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,16,1.09 [0.95-1.25],0.218984136146454,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,16,1.04 [0.98-1.11],0.220445316167362,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLTP,Phospholipid transfer protein,Inverse variance weighted,16,0.93 [0.82-1.05],0.22277622474091,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,16,1.06 [0.96-1.17],0.225102457803695,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,16,1.1 [0.94-1.3],0.225255090971627,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.06 [0.97-1.16],0.227471423860093,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,16,1.12 [0.93-1.34],0.228674081915357,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP8,Neutrophil collagenase,Inverse variance weighted,16,0.96 [0.9-1.02],0.229588491955034,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,16,1.09 [0.95-1.24],0.232337764790344,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPB6,Heat shock protein beta-6,Inverse variance weighted,16,0.95 [0.87-1.03],0.23289406104811,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,16,1.06 [0.97-1.15],0.236566700026333,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,16,0.92 [0.8-1.06],0.237359220344563,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,16,1.11 [0.93-1.31],0.239880957659802,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD59,CD59 glycoprotein,Inverse variance weighted,16,0.95 [0.87-1.03],0.239971305068051,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,16,1.11 [0.93-1.32],0.241013370409979,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCN2,Transcobalamin-2,Inverse variance weighted,16,1.04 [0.97-1.12],0.241829465453869,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.1 [0.94-1.29],0.242017234495988,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,16,1.04 [0.97-1.11],0.242838243175634,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,16,1.12 [0.93-1.35],0.242884311869297,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOMO1,Nodal modulator 1,Inverse variance weighted,16,1.07 [0.95-1.21],0.243522306979581,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,16,1.1 [0.94-1.3],0.243593874822812,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,16,1.04 [0.97-1.12],0.245369008894301,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,16,0.9 [0.75-1.08],0.249071890464576,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FSTL3,Follistatin-related protein 3,Inverse variance weighted,16,0.94 [0.86-1.04],0.250602508261002,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,16,0.93 [0.82-1.05],0.251553352925817,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,16,1.06 [0.96-1.18],0.252249170651742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,16,1.43 [0.78-2.64],0.252439967299352,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,16,0.96 [0.88-1.03],0.253445569210492,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,16,1.07 [0.96-1.19],0.253612080279871,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,16,0.93 [0.81-1.06],0.253852998594253,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD160,CD160 antigen,Inverse variance weighted,16,1.17 [0.89-1.53],0.254327113126876,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300A,CMRF35-like molecule 8,Inverse variance weighted,16,1.1 [0.93-1.3],0.258230692420668,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,16,1.06 [0.96-1.17],0.259829726221068,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH2,Cadherin-2,Inverse variance weighted,16,1.07 [0.95-1.2],0.259864186977792,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,16,1.04 [0.97-1.11],0.260189324189459,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,16,1.08 [0.95-1.22],0.260213755912603,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,16,1.06 [0.95-1.19],0.264889704631761,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,16,1.06 [0.96-1.17],0.266753996121279,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,1.04 [0.97-1.13],0.268757496555734,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACTN2,Alpha-actinin-2,Inverse variance weighted,16,0.95 [0.88-1.04],0.274080385060742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CIT,Citron Rho-interacting kinase,Inverse variance weighted,16,1.05 [0.96-1.16],0.274193043689431,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,16,1.08 [0.94-1.23],0.275508891009443,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDN1,Endothelin-1,Inverse variance weighted,16,0.95 [0.87-1.04],0.276436349831347,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,16,1.05 [0.96-1.13],0.27862762956533,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRELP,Prolargin,Inverse variance weighted,16,0.96 [0.9-1.03],0.279313524107221,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRH,Corticoliberin,Inverse variance weighted,16,1.06 [0.95-1.19],0.280282193443997,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGAV,Integrin alpha-V,Inverse variance weighted,16,0.93 [0.82-1.06],0.281073230405666,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFI,Complement factor I,Inverse variance weighted,16,1.12 [0.91-1.38],0.281174224639955,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,16,1.04 [0.97-1.1],0.281655061981974,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHGA,Chromogranin-A,Inverse variance weighted,16,0.95 [0.85-1.05],0.282189322779385,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,16,0.96 [0.89-1.03],0.282395977115919,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,16,1.06 [0.95-1.19],0.284271543898577,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3C,Protein FAM3C,Inverse variance weighted,16,1.04 [0.97-1.13],0.285230622514406,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,16,1.09 [0.93-1.28],0.28582347852972,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,16,1.12 [0.91-1.38],0.289437374820966,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS2,Trypsin-2,Inverse variance weighted,16,1.04 [0.97-1.11],0.290496942563742,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,16,1.12 [0.91-1.38],0.29178171067061,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,16,1.1 [0.92-1.32],0.291866022980687,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,1.06 [0.95-1.18],0.292423918843179,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,16,0.94 [0.83-1.06],0.294120409739078,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,16,1.12 [0.91-1.37],0.295298414590246,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RNASE6,Ribonuclease K6,Inverse variance weighted,16,1.07 [0.94-1.23],0.295524623082706,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Inverse variance weighted,16,1.05 [0.96-1.15],0.296273695720554,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.05 [0.96-1.16],0.29693655265801,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LGALS3,Galectin-3,Inverse variance weighted,16,1.05 [0.96-1.14],0.29718839285225,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN5,CCN family member 5,Inverse variance weighted,16,0.96 [0.88-1.04],0.297214463097547,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,16,1.05 [0.95-1.17],0.298453340033787,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,16,1.07 [0.94-1.21],0.30075494516167,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,16,1.06 [0.95-1.17],0.300996124119974,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,16,0.92 [0.78-1.08],0.301245041319988,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFNA4,Ephrin-A4,Inverse variance weighted,16,1.09 [0.93-1.28],0.305055134010451,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,16,1.08 [0.94-1.24],0.307675645619298,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BCAN,Brevican core protein,Inverse variance weighted,16,0.96 [0.9-1.04],0.308669095059381,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF3,Trefoil factor 3,Inverse variance weighted,16,1.05 [0.96-1.15],0.308784159163375,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,16,1.08 [0.93-1.25],0.308790342760979,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF1,Trefoil factor 1,Inverse variance weighted,16,1.03 [0.97-1.1],0.310651832856091,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,16,1.04 [0.96-1.13],0.311940744585495,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,16,1.15 [0.88-1.51],0.312083271843984,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.05 [0.96-1.14],0.317941927259942,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL10,Interleukin-10,Inverse variance weighted,16,1.05 [0.95-1.16],0.321933808454101,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPT2,Angiopoietin-2,Inverse variance weighted,16,1.06 [0.94-1.2],0.323094966912804,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOM,Apolipoprotein M,Inverse variance weighted,16,1.11 [0.9-1.37],0.324073644960632,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,16,1.05 [0.95-1.17],0.32562817565487,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,16,1.08 [0.93-1.25],0.327910153336115,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,16,0.93 [0.8-1.08],0.328088081269929,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD276,CD276 antigen,Inverse variance weighted,16,0.93 [0.8-1.08],0.32936052675471,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GUSB,Beta-glucuronidase,Inverse variance weighted,16,1.04 [0.96-1.13],0.330645078209267,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,16,0.96 [0.88-1.05],0.331492234912094,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNXB,Tenascin-X,Inverse variance weighted,16,0.95 [0.85-1.06],0.333089916896208,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGF21,Fibroblast growth factor 21,Inverse variance weighted,16,1.15 [0.86-1.54],0.333363123500888,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.07 [0.94-1.22],0.334177861551076,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PALM2,Paralemmin-2,Inverse variance weighted,16,0.97 [0.91-1.03],0.33523492279768,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,16,1.05 [0.95-1.16],0.341782916149085,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300E,CMRF35-like molecule 2,Inverse variance weighted,16,1.13 [0.88-1.46],0.343877670800308,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,16,1.05 [0.95-1.15],0.344121930896674,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,16,1.04 [0.96-1.12],0.346484055922665,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,16,1.05 [0.95-1.17],0.349565342365295,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,16,1.06 [0.93-1.21],0.350385527455316,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FURIN,Furin,Inverse variance weighted,16,1.11 [0.89-1.4],0.353624219905355,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD55,Complement decay-accelerating factor,Inverse variance weighted,16,0.94 [0.83-1.07],0.355105103254826,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Inverse variance weighted,16,0.95 [0.86-1.05],0.357109465953738,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,16,0.95 [0.84-1.06],0.358421553650576,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,16,1.09 [0.91-1.3],0.358909467506469,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.96 [0.87-1.05],0.35959046062902,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,16,0.96 [0.88-1.05],0.360067562019887,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,16,1.05 [0.95-1.16],0.360956224977879,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD27,CD27 antigen,Inverse variance weighted,16,1.1 [0.9-1.33],0.361087467120766,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NFASC,Neurofascin,Inverse variance weighted,16,1.04 [0.96-1.13],0.36279671743532,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRSS8,Prostasin,Inverse variance weighted,16,1.07 [0.92-1.25],0.36375762633042,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,16,1.05 [0.94-1.17],0.364422013062443,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,16,0.94 [0.83-1.07],0.366041188893684,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,16,1.07 [0.92-1.25],0.366826784971348,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,16,1.05 [0.95-1.15],0.367933822380382,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,16,1.04 [0.96-1.13],0.368642649460962,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.06 [0.93-1.2],0.369526771494763,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,16,1.04 [0.95-1.13],0.373248232981713,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300C,CMRF35-like molecule 6,Inverse variance weighted,16,1.08 [0.91-1.28],0.378794176409352,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NECTIN4,Nectin-4,Inverse variance weighted,16,0.94 [0.81-1.09],0.381147660131893,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,STAB2,Stabilin-2,Inverse variance weighted,16,1.04 [0.95-1.13],0.38192823540486,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FETUB,Fetuin-B,Inverse variance weighted,16,1.03 [0.96-1.12],0.382925916603243,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,16,1.05 [0.94-1.18],0.383065826494118,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,16,0.97 [0.89-1.04],0.383936530253716,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FOLR2,Folate receptor beta,Inverse variance weighted,16,0.94 [0.82-1.08],0.384755842927299,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,16,0.95 [0.84-1.07],0.385484883059583,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,16,1.08 [0.91-1.27],0.388836562893653,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCG,Pro-glucagon,Inverse variance weighted,16,1.06 [0.92-1.22],0.389027807306151,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TPR,Nucleoprotein TPR,Inverse variance weighted,16,1.04 [0.95-1.13],0.390435799273169,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,16,0.94 [0.8-1.09],0.395221003629893,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,16,0.96 [0.87-1.06],0.395720133793175,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD7,T-cell antigen CD7,Inverse variance weighted,16,1.11 [0.87-1.42],0.396799974158093,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MATN2,Matrilin-2,Inverse variance weighted,16,1.04 [0.95-1.15],0.397721112514405,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CALB1,Calbindin,Inverse variance weighted,16,0.97 [0.9-1.04],0.401012557860135,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.96 [0.86-1.06],0.401052263100044,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.93 [0.8-1.1],0.401270366574942,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,16,1.06 [0.93-1.21],0.402147726005088,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,16,1.05 [0.93-1.19],0.40228871407652,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,16,1.03 [0.96-1.1],0.403218222768937,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,16,0.97 [0.89-1.05],0.409131257831971,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADM,Pro-adrenomedullin,Inverse variance weighted,16,1.04 [0.95-1.12],0.41094202662622,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NGRN,Neugrin,Inverse variance weighted,16,1.03 [0.96-1.11],0.411714055964663,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CNTN1,Contactin-1,Inverse variance weighted,16,0.95 [0.84-1.07],0.413333815233937,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,16,1.05 [0.93-1.2],0.414584334953447,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,16,1.03 [0.96-1.1],0.415401000702884,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,F9,Coagulation factor IX,Inverse variance weighted,16,1.11 [0.86-1.42],0.418672718321921,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,1.06 [0.92-1.23],0.418879118714841,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,16,1.09 [0.89-1.33],0.423176056056739,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,16,0.93 [0.79-1.11],0.423532666852796,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,16,0.89 [0.66-1.19],0.424484373300446,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,16,1.05 [0.94-1.16],0.425022909671486,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,16,0.97 [0.89-1.05],0.425797807495585,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,16,0.95 [0.83-1.08],0.426532996951108,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRP1,Neuropilin-1,Inverse variance weighted,16,0.94 [0.81-1.1],0.426572388688392,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,16,0.97 [0.9-1.05],0.426728569046956,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,16,1.05 [0.94-1.17],0.427509760278441,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SNCG,Gamma-synuclein,Inverse variance weighted,16,0.98 [0.93-1.03],0.431679958124375,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,16,0.96 [0.85-1.07],0.431854654913041,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MPO,Myeloperoxidase,Inverse variance weighted,16,1.03 [0.95-1.12],0.432609020353904,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,16,1.1 [0.87-1.38],0.433374236580376,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,16,1.03 [0.96-1.1],0.433613174451674,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,16,1.04 [0.95-1.14],0.436917432583211,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,16,1.05 [0.93-1.17],0.437457047231603,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,16,0.96 [0.85-1.07],0.438141147974014,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,16,1.06 [0.92-1.22],0.439186527428497,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPIND1,Heparin cofactor 2,Inverse variance weighted,16,1.11 [0.86-1.43],0.442862892879528,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,16,0.96 [0.88-1.06],0.448360282263223,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,16,0.97 [0.89-1.05],0.448442151430122,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AMN,Protein amnionless,Inverse variance weighted,16,1.04 [0.95-1.13],0.448750374934719,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,16,1.03 [0.95-1.12],0.450120352678425,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MFGE8,Lactadherin,Inverse variance weighted,16,1.06 [0.91-1.25],0.450422166496597,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COLEC12,Collectin-12,Inverse variance weighted,16,0.97 [0.89-1.05],0.450612180950909,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,16,0.93 [0.76-1.13],0.460529738901974,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,16,0.98 [0.92-1.04],0.461426113722138,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,16,1.04 [0.94-1.14],0.461643778929235,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DLL1,Delta-like protein 1,Inverse variance weighted,16,1.06 [0.91-1.22],0.463933892029948,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,16,0.96 [0.86-1.07],0.465894158774303,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GDF15,Growth/differentiation factor 15,Inverse variance weighted,16,1.03 [0.95-1.12],0.465925510462436,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD48,CD48 antigen,Inverse variance weighted,16,1.11 [0.84-1.46],0.467922599304306,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,16,1.04 [0.94-1.14],0.469030685675499,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,16,1.03 [0.95-1.11],0.471525324314777,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PI3,Elafin,Inverse variance weighted,16,1.04 [0.93-1.16],0.480780805783505,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINB8,Serpin B8,Inverse variance weighted,16,1.02 [0.96-1.09],0.480823945874827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHRDL1,Chordin-like protein 1,Inverse variance weighted,16,0.97 [0.88-1.06],0.481069081754527,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,16,1.03 [0.95-1.11],0.48483635086117,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,16,1.04 [0.94-1.15],0.486095734227219,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,16,1.03 [0.95-1.12],0.489421762545496,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,16,1.03 [0.94-1.14],0.499225849177764,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,16,1.07 [0.88-1.3],0.499796303676335,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,16,0.97 [0.91-1.05],0.500572712156508,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,16,0.96 [0.84-1.09],0.504998013380579,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,16,1.03 [0.95-1.12],0.505826164110039,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,16,1.06 [0.9-1.24],0.50664210480192,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,16,1.1 [0.84-1.44],0.506681798059438,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,16,1.09 [0.84-1.43],0.510422869665578,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL19,Interleukin-19,Inverse variance weighted,16,1.04 [0.92-1.19],0.514153189872876,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FST,Follistatin,Inverse variance weighted,16,1.08 [0.85-1.38],0.516535096747566,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,16,0.98 [0.9-1.05],0.517802541432459,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,16,0.96 [0.86-1.08],0.518139016448324,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CPM,Carboxypeptidase M,Inverse variance weighted,16,1.04 [0.92-1.17],0.520129158855222,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRND,Prion-like protein doppel,Inverse variance weighted,16,0.96 [0.85-1.09],0.520614573166224,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PVR,Poliovirus receptor,Inverse variance weighted,16,1.03 [0.94-1.13],0.523063080401606,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,16,0.98 [0.9-1.05],0.525914968013012,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEPTIN8,Septin-8,Inverse variance weighted,16,1.02 [0.96-1.09],0.525943757370197,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PCDH17,Protocadherin-17,Inverse variance weighted,16,1.06 [0.88-1.28],0.526845925255021,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOA2,Apolipoprotein A-II,Inverse variance weighted,16,1.02 [0.95-1.11],0.530774982911852,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RTN4R,Reticulon-4 receptor,Inverse variance weighted,16,1.04 [0.91-1.19],0.530781826701769,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,16,0.95 [0.79-1.13],0.534439581214309,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IDS,Iduronate 2-sulfatase,Inverse variance weighted,16,0.97 [0.9-1.06],0.537249838933392,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BSG,Basigin,Inverse variance weighted,16,0.96 [0.83-1.1],0.538607220641907,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,16,0.97 [0.86-1.08],0.539916091569379,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,16,1.02 [0.96-1.09],0.539943541511646,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PREB,Prolactin regulatory element-binding protein,Inverse variance weighted,16,0.98 [0.9-1.05],0.540884477602824,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,C7,Complement component C7,Inverse variance weighted,16,1.02 [0.95-1.11],0.540903680517531,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,16,1.03 [0.93-1.14],0.545619444807529,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK4,Kallikrein-4,Inverse variance weighted,16,0.97 [0.89-1.06],0.545863910402259,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,16,0.98 [0.9-1.06],0.546617593627776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,16,0.97 [0.86-1.08],0.548091897111751,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,16,1.04 [0.92-1.17],0.548144925812306,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.02 [0.95-1.11],0.551871262885593,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,16,1.02 [0.95-1.11],0.554509889813186,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,16,0.97 [0.89-1.06],0.555193832298523,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MANSC4,MANSC domain-containing protein 4,Inverse variance weighted,16,1.02 [0.95-1.1],0.559150941645736,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,16,1.02 [0.95-1.1],0.5597781303603,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.07 [0.86-1.33],0.560725532347719,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCTN3,Tectonic-3,Inverse variance weighted,16,1.03 [0.93-1.13],0.562413919406083,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,16,1.04 [0.91-1.18],0.565942838021461,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,16,1.02 [0.95-1.09],0.567014461499196,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.97 [0.87-1.08],0.569598079294046,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,16,1.02 [0.95-1.09],0.570012688969515,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SHISA5,Protein shisa-5,Inverse variance weighted,16,1.04 [0.9-1.2],0.570774122863452,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MB,Myoglobin,Inverse variance weighted,16,0.97 [0.88-1.08],0.570919694179092,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,REN,Renin,Inverse variance weighted,16,1.02 [0.95-1.09],0.571826345262266,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,16,1.02 [0.95-1.11],0.571910870111529,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,16,1.03 [0.94-1.12],0.572491882263567,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GM2A,Ganglioside GM2 activator,Inverse variance weighted,16,1.02 [0.94-1.12],0.575290262487567,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,XG,Glycoprotein Xg,Inverse variance weighted,16,0.97 [0.89-1.07],0.578129858786923,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,16,1.05 [0.89-1.24],0.578241875888374,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,S100P,Protein S100-P,Inverse variance weighted,16,0.97 [0.89-1.07],0.578455454206626,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEMA3G,Semaphorin-3G,Inverse variance weighted,16,1.03 [0.93-1.13],0.584326367580684,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,16,0.96 [0.85-1.1],0.585323062588726,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGA2,Integrin alpha-2,Inverse variance weighted,16,1.02 [0.96-1.08],0.598511164325652,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,16,1.02 [0.94-1.12],0.599509447237268,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP3,Stromelysin-1,Inverse variance weighted,16,0.98 [0.93-1.04],0.601075750094442,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,16,1.02 [0.95-1.1],0.601791695345866,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,16,0.97 [0.84-1.1],0.601885999826727,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDSN,Corneodesmosin,Inverse variance weighted,16,1.04 [0.9-1.19],0.60348753658287,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,16,1.03 [0.91-1.17],0.605143021607802,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,16,1.02 [0.96-1.08],0.606405767379378,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,16,1.02 [0.94-1.11],0.61000720653718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,16,1.07 [0.83-1.38],0.610621808798585,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,STC1,Stanniocalcin-1,Inverse variance weighted,16,1.02 [0.94-1.12],0.614843847557062,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTA4H,Leukotriene A-4 hydrolase,Inverse variance weighted,16,0.98 [0.91-1.06],0.616240385992177,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,16,0.98 [0.89-1.07],0.618211339831637,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RTBDN,Retbindin,Inverse variance weighted,16,1.02 [0.94-1.1],0.619411897087995,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,16,1.02 [0.94-1.12],0.621942661515633,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,16,1.05 [0.87-1.25],0.622965295101634,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,16,1.04 [0.89-1.2],0.623987063505476,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,16,0.98 [0.89-1.07],0.624065233616982,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.05 [0.88-1.25],0.625029375170143,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AMBP,Protein AMBP,Inverse variance weighted,16,0.98 [0.9-1.07],0.626678029705098,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BAP18,Chromatin complexes subunit BAP18,Inverse variance weighted,16,1.03 [0.92-1.15],0.627423594295042,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,16,1.02 [0.95-1.09],0.628069139727056,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,16,0.98 [0.91-1.06],0.630263084530718,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRG2,Bone marrow proteoglycan,Inverse variance weighted,16,0.96 [0.79-1.15],0.631858515454875,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VWC2,Brorin,Inverse variance weighted,16,1.02 [0.95-1.1],0.634194009159043,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD302,CD302 antigen,Inverse variance weighted,16,1.02 [0.93-1.12],0.63569759778536,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,16,1.02 [0.95-1.09],0.637427262321026,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP7,Matrilysin,Inverse variance weighted,16,1.02 [0.94-1.1],0.637430268431029,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,16,0.98 [0.88-1.08],0.643080494547005,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,16,1.03 [0.9-1.18],0.643433464184844,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYBPC2,"Myosin-binding protein C, fast-type",Inverse variance weighted,16,1.02 [0.95-1.08],0.644834230348365,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSV,Cathepsin L2,Inverse variance weighted,16,0.98 [0.9-1.07],0.646387520644035,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,16,0.98 [0.89-1.08],0.650354564868569,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OGN,Mimecan,Inverse variance weighted,16,0.98 [0.92-1.06],0.650359607182083,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COMP,Cartilage oligomeric matrix protein,Inverse variance weighted,16,0.97 [0.87-1.09],0.651363730600122,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL15,Interleukin-15,Inverse variance weighted,16,0.96 [0.8-1.15],0.653968090352106,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH6,Cadherin-6,Inverse variance weighted,16,0.97 [0.87-1.1],0.65543984991366,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,16,1.05 [0.86-1.27],0.655600431171268,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,16,1.04 [0.88-1.23],0.655654025847254,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,S100A12,Protein S100-A12,Inverse variance weighted,16,0.99 [0.92-1.05],0.657982309162328,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,16,1.03 [0.92-1.15],0.65877546895397,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RCC1,Regulator of chromosome condensation,Inverse variance weighted,16,0.98 [0.9-1.07],0.658953664457378,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCRLB,Fc receptor-like B,Inverse variance weighted,16,1.01 [0.95-1.08],0.659994225923159,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,16,1.02 [0.94-1.1],0.661686864818626,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,16,1.02 [0.93-1.12],0.662902432863868,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPP1,Osteopontin,Inverse variance weighted,16,1.02 [0.93-1.12],0.666257540691828,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,16,1.02 [0.92-1.14],0.669197517533207,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ENAH,Protein enabled homolog,Inverse variance weighted,16,1.02 [0.93-1.11],0.669607466731937,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,16,0.97 [0.85-1.11],0.671803715134901,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,16,0.98 [0.91-1.06],0.671884374099198,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,16,0.98 [0.87-1.1],0.672223767684379,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,16,1.02 [0.94-1.1],0.675156213888171,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PXN,Paxillin,Inverse variance weighted,16,1.02 [0.94-1.1],0.675556643920031,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RSPO3,R-spondin-3,Inverse variance weighted,16,1.02 [0.95-1.09],0.675701889792821,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,16,1.02 [0.93-1.13],0.676919751894477,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,16,1.04 [0.87-1.23],0.679066928066797,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SELENOP,Selenoprotein P,Inverse variance weighted,16,1.02 [0.92-1.14],0.679588447349224,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MILR1,Allergin-1,Inverse variance weighted,16,0.97 [0.85-1.11],0.685777815290812,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,16,1.02 [0.93-1.12],0.686371082889096,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GHRL,Appetite-regulating hormone,Inverse variance weighted,16,1.02 [0.93-1.12],0.68653550304553,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FAM3B,Protein FAM3B,Inverse variance weighted,16,0.99 [0.92-1.06],0.689358649284058,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH1,Cadherin-1,Inverse variance weighted,16,1.01 [0.95-1.09],0.689833288438776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,16,1.02 [0.92-1.13],0.692385484991081,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FSTL1,Follistatin-related protein 1,Inverse variance weighted,16,0.97 [0.82-1.14],0.693530137192161,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,16,0.98 [0.88-1.09],0.699505765564559,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPT,Dermatopontin,Inverse variance weighted,16,1.02 [0.93-1.11],0.70039932968758,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,16,1.02 [0.93-1.11],0.70061621998069,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,16,0.98 [0.88-1.09],0.70232175194827,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CX3CL1,Fractalkine,Inverse variance weighted,16,1.02 [0.91-1.15],0.704067751883909,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,16,1.03 [0.89-1.18],0.704106180448368,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Inverse variance weighted,16,1.02 [0.93-1.11],0.708755731182204,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,16,1.03 [0.9-1.17],0.713038900916698,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,16,1.02 [0.93-1.11],0.716305015234173,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK8,Kallikrein-8,Inverse variance weighted,16,0.98 [0.87-1.1],0.716350404915955,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ROBO1,Roundabout homolog 1,Inverse variance weighted,16,1.03 [0.87-1.21],0.716394119805418,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NPPB,Natriuretic peptides B,Inverse variance weighted,16,1.01 [0.95-1.08],0.718531429422232,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,16,0.98 [0.88-1.09],0.723116667585169,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,16,1.01 [0.94-1.09],0.724777935794018,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.03 [0.89-1.18],0.724835567576067,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCG3,Secretogranin-3,Inverse variance weighted,16,0.98 [0.89-1.08],0.727269593781232,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCN4,CCN family member 4,Inverse variance weighted,16,0.99 [0.93-1.05],0.729054670718163,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRTN3,Myeloblastin,Inverse variance weighted,16,0.98 [0.89-1.09],0.737028347489453,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,16,1.01 [0.95-1.08],0.737805081486629,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,16,0.99 [0.92-1.06],0.739323189642492,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CDH3,Cadherin-3,Inverse variance weighted,16,1.03 [0.86-1.23],0.740324965358313,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANXA5,Annexin A5,Inverse variance weighted,16,1.02 [0.93-1.11],0.745851700913522,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,16,1.01 [0.94-1.1],0.747168809139911,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,16,1.01 [0.94-1.09],0.747613434295057,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,16,1.02 [0.89-1.17],0.74944829921532,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,16,0.98 [0.88-1.1],0.750867684903422,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,16,0.99 [0.91-1.07],0.75149212910985,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,16,0.98 [0.9-1.08],0.753237567165307,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFRC,Transferrin receptor protein 1,Inverse variance weighted,16,1.02 [0.92-1.13],0.754056076546468,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD99,CD99 antigen,Inverse variance weighted,16,0.98 [0.86-1.12],0.754236753603278,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,16,1.02 [0.91-1.14],0.757486402267605,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HJV,Hemojuvelin,Inverse variance weighted,16,1.01 [0.93-1.1],0.75987107973715,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.98 [0.89-1.09],0.761535538546612,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.01 [0.94-1.09],0.762611751605316,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CFD,Complement factor D,Inverse variance weighted,16,0.98 [0.89-1.09],0.763559363949776,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CD93,Complement component C1q receptor,Inverse variance weighted,16,0.98 [0.84-1.14],0.770730673815129,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,16,0.99 [0.9-1.08],0.771270034068593,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,16,0.99 [0.9-1.08],0.771508280289136,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DRAXIN,Draxin,Inverse variance weighted,16,0.99 [0.91-1.07],0.773405928187354,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,16,1.02 [0.89-1.17],0.778210378089211,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,16,0.99 [0.9-1.08],0.780982617714479,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MMP13,Collagenase 3,Inverse variance weighted,16,0.99 [0.92-1.06],0.782393780500311,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,16,0.99 [0.9-1.08],0.785236242095728,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TCOF1,Treacle protein,Inverse variance weighted,16,1.01 [0.92-1.11],0.78551567692332,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,AREG,Amphiregulin,Inverse variance weighted,16,0.98 [0.87-1.12],0.787804777337141,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,16,1.02 [0.89-1.16],0.788973588959954,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DSC2,Desmocollin-2,Inverse variance weighted,16,1.02 [0.86-1.22],0.793339100717749,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,UMOD,Uromodulin,Inverse variance weighted,16,0.99 [0.9-1.09],0.796184631069555,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGAM,Integrin alpha-M,Inverse variance weighted,16,0.98 [0.83-1.15],0.796260277752664,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCT,Secretin,Inverse variance weighted,16,0.99 [0.91-1.07],0.79918915256962,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,16,1.02 [0.89-1.16],0.799723867660219,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,16,1.01 [0.91-1.13],0.801553122849824,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPON1,Spondin-1,Inverse variance weighted,16,0.99 [0.89-1.09],0.803040513560132,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CHGB,Secretogranin-1,Inverse variance weighted,16,0.99 [0.9-1.09],0.804524636555907,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NEFL,Neurofilament light polypeptide,Inverse variance weighted,16,0.99 [0.93-1.06],0.805326538197232,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,16,0.99 [0.91-1.07],0.809118026357899,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DTNB,Dystrobrevin beta,Inverse variance weighted,16,1.01 [0.94-1.07],0.813599118132253,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,16,1.01 [0.93-1.09],0.814247623946699,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,16,1.01 [0.94-1.09],0.816632237978075,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NRP2,Neuropilin-2,Inverse variance weighted,16,1.01 [0.92-1.11],0.819432770033906,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,16,0.98 [0.85-1.13],0.821357079328475,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,16,1.01 [0.91-1.12],0.822797881554868,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CAPG,Macrophage-capping protein,Inverse variance weighted,16,0.99 [0.93-1.06],0.824311524790102,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,16,1.01 [0.93-1.09],0.826490780375837,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,16,1.01 [0.91-1.12],0.828611774597299,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,16,0.99 [0.9-1.09],0.830541216353782,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,16,1.01 [0.94-1.07],0.833229557459865,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADIPOQ,Adiponectin,Inverse variance weighted,16,1.01 [0.94-1.08],0.838018906214076,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CKB,Creatine kinase B-type,Inverse variance weighted,16,1.02 [0.86-1.2],0.848903786043005,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,16,0.99 [0.92-1.07],0.8490644390371,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,16,1.01 [0.91-1.12],0.850663271372153,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,16,1.01 [0.87-1.18],0.853433744836546,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,16,1.01 [0.94-1.08],0.857554062525033,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CELA2A,Chymotrypsin-like elastase family member 2A,Inverse variance weighted,16,1.01 [0.94-1.08],0.857670499586229,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CTSO,Cathepsin O,Inverse variance weighted,16,0.99 [0.89-1.11],0.860515811574908,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLXNB2,Plexin-B2,Inverse variance weighted,16,1.01 [0.88-1.17],0.861204276570855,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,16,1.01 [0.93-1.09],0.866556166461805,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,16,1.01 [0.94-1.08],0.867743975912508,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,16,0.99 [0.91-1.08],0.870932322291744,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,16,0.99 [0.89-1.1],0.870944937327841,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,16,1.01 [0.9-1.13],0.876787880243185,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SDC1,Syndecan-1,Inverse variance weighted,16,0.99 [0.83-1.17],0.879077973310826,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,POMC,Pro-opiomelanocortin,Inverse variance weighted,16,0.99 [0.91-1.09],0.880554323504485,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ACAN,Aggrecan core protein,Inverse variance weighted,16,1.01 [0.91-1.12],0.882299206058748,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VCAN,Versican core protein,Inverse variance weighted,16,0.99 [0.9-1.1],0.883909846590166,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,16,0.99 [0.91-1.09],0.887252869349906,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,16,1 [0.94-1.06],0.887280536208923,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,16,1.01 [0.93-1.09],0.890298595723571,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,16,0.99 [0.93-1.07],0.891080815367558,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,16,0.99 [0.89-1.11],0.89273686523638,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,16,0.99 [0.92-1.07],0.895469661744304,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,16,1 [0.93-1.08],0.897425356749809,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TFF2,Trefoil factor 2,Inverse variance weighted,16,1 [0.92-1.07],0.898650761527497,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EGFR,Epidermal growth factor receptor,Inverse variance weighted,16,1.01 [0.87-1.17],0.90211532642822,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FCN1,Ficolin-1,Inverse variance weighted,16,1.01 [0.89-1.14],0.907100552697414,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LAYN,Layilin,Inverse variance weighted,16,1.01 [0.91-1.11],0.907972282485184,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,16,1 [0.93-1.08],0.909094961150834,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,16,1 [0.93-1.09],0.910240463084279,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,16,1 [0.92-1.08],0.91374821614809,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,16,1.01 [0.86-1.19],0.914595855938371,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ULBP2,UL16-binding protein 2,Inverse variance weighted,16,1 [0.93-1.09],0.915999925767618,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ZHX2,Zinc fingers and homeoboxes protein 2,Inverse variance weighted,16,1 [0.91-1.09],0.916352845664383,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,16,0.99 [0.89-1.11],0.924699669493678,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,THBD,Thrombomodulin,Inverse variance weighted,16,1.01 [0.89-1.14],0.925317804215741,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,16,1 [0.91-1.11],0.925407260025878,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,16,1 [0.93-1.08],0.929286662260884,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,WNT9A,Protein Wnt-9a,Inverse variance weighted,16,1 [0.91-1.09],0.933930275022581,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,16,0.99 [0.86-1.15],0.937793575994429,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,16,1 [0.9-1.11],0.9389791272056,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ANXA10,Annexin A10,Inverse variance weighted,16,1 [0.94-1.07],0.944764825093186,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,16,1 [0.91-1.1],0.94609880955659,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,16,1 [0.91-1.1],0.953132078491833,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KLK11,Kallikrein-11,Inverse variance weighted,16,1 [0.91-1.1],0.954476065859669,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PKD2,Polycystin-2,Inverse variance weighted,16,1 [0.86-1.17],0.958233578981308,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,NCAN,Neurocan core protein,Inverse variance weighted,16,1 [0.92-1.09],0.958428160218647,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,16,1 [0.91-1.11],0.963856831026136,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,16,1 [0.91-1.09],0.964059419142883,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,16,1 [0.93-1.08],0.964179450996441,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,16,1 [0.94-1.07],0.966836189590711,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,16,1 [0.9-1.12],0.969165955772873,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,KIF1C,Kinesin-like protein KIF1C,Inverse variance weighted,16,1 [0.93-1.08],0.973331000401396,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,16,1 [0.93-1.08],0.975478207064581,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,16,1 [0.93-1.08],0.975563860133443,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,16,1 [0.91-1.09],0.97695179635226,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,MME,Neprilysin,Inverse variance weighted,16,1 [0.92-1.09],0.979497211410684,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,EPO,Erythropoietin,Inverse variance weighted,16,1 [0.91-1.11],0.981953581617208,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SPON2,Spondin-2,Inverse variance weighted,16,1 [0.94-1.07],0.982431662440386,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,FGF23,Fibroblast growth factor 23,Inverse variance weighted,16,1 [0.91-1.11],0.982713182714186,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,16,1 [0.84-1.19],0.985985090267492,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,16,1 [0.86-1.16],0.986280137631844,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CXCL14,C-X-C motif chemokine 14,Inverse variance weighted,16,1 [0.92-1.08],0.988558169146042,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,16,1 [0.94-1.07],0.992182416385086,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,RETN,Resistin,Inverse variance weighted,16,1 [0.91-1.1],0.992286516785945,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,16,1 [0.94-1.07],0.992295819083946,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,HGF,Hepatocyte growth factor,Inverse variance weighted,16,1 [0.89-1.12],0.993072706863224,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,16,1 [0.89-1.12],0.995982242133284,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,CLGN,Calmegin,Inverse variance weighted,16,1 [0.89-1.12],0.998678493865887,trans
